Patheon offers extensive sterile product development and commercial manufacturing capabilities, including world-class expertise in lyophilization and ready-to-use dose formats.
As the healthcare industry moves away from clinical visits, notably those for injected therapies, Patheon is providing pharmaceutical companies with new ways to capitalize the opportunities of the evolving marketplace. In early 2014, our state-of-the-art commercial-scale GMP manufacturing suite for prefilled syringes and cartridges will be fully operational with an annual capacity of 37 million units.
Whether you are developing a new drug or exploring lifecycle management opportunities, Patheon gives you access to the advanced formulation expertise and latest technologies to bring to the world a high-quality sterile product. -